Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03304886
Other study ID # John Henry study
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 28, 2018
Est. completion date December 30, 2019

Study information

Verified date October 2020
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose of the study is to assess the diagnostic accuracy of an on- line questionnaire in comparison to a semi-structured interview administered by a trained interviewer.


Description:

The worldwide current gold standard for diagnosing headaches is the International Classification of Headache Disorders (ICHD 3 beta). Adhering strictly to ICHD criteria has been problematic for accurately diagnosing patients in the clinic and as for clinical trials. To address these issues, an online instrument was developed that successfully diagnosis common primary and secondary headache disorders. In this research Investigator hopes to demonstrate an on- line questionnaire is non inferior to a semi-structured interview for accurately diagnosing different types of headaches (for example: episodic migraine vs. non episodic migraine, chronic migraine vs. non chronic migraine, episodic tension-type vs. non-episodic tension type, chronic tension-type headache vs. non chronic tension-type headache, medication overuse headache vs. non medication overuse headache, post traumatic headache vs. non post traumatic headache).

Participants will be screened by telephone to see if participants meet the criteria for taking part in this research study. Once participant is deemed eligible,the participants will then be randomized in a 1:1 ratio to complete either the semi-structured interview over the phone first and then complete the online questionnaire or vice versa. Study is expected to enroll 500 participants with headache and healthy controls.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date December 30, 2019
Est. primary completion date October 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Female or male subjects age between age 18-65(inclusive),

2. Subjects must agree to sign online informed consent;

3. Subject must be able to understand and willing to complete both evaluations in English

4. Willing to comply with study instructions.

5. Agree not to Rely or act on any diagnosis given to them in the study

Exclusion Criteria:

1. Presence of Disorders listed in groups 5-13 of The International Headache Society Classification of Head and Facial Pain (Headache Classification Committee of the International Headache Society, 2015 except for post traumatic headache and medication overuse headache);

1a. History of brain tumor, brain surgery

1b. History of brain infection such as meningitis, encephalitis, or meningoencephalitis

1c. History of any significant current or previous brain dysfunction

1d. Regular use of illicit drugs.

2. Known significant medical or psychiatric disease or abnormal laboratory data that would preclude entry into this study.

3. Subjects with - significant cognitive impairment such as dementia, active psychiatric disease such as schizophrenia.

4. Subjects with physical limitations to participate in the on-line or phone interview impossible.

5. Non-English speaking patients

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Stanford University, School of Medicine Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary On-line questionnaire accuracy for Diagnosing episodic migraine An on- line questionnaire is non inferior to a semi-structured interview for accurately diagnosing episodic migraine vs non episodic migraine, chronic migraine vs. non chronic migraine. We will compare the 4 primary (chronic and episodic migraine, chronic and episodic tension-type headache) obtained on each of the two evaluations for reliability using recognized statistical tools: This analysis will be conducted by independent reviewers, not the developers of either instrument 2 -2.5 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03632928 - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed NCT00246350 - Spinal Manipulation for Treatment of Chronic Headaches Phase 2
Completed NCT05404113 - Sustained Natural Apophyseal Glide and Deep Friction Massage in Patients With Cervicogenic Headache N/A
Recruiting NCT03416114 - RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres N/A
Enrolling by invitation NCT04976985 - Osteopathic Manipulative Treatment and Migraine Headaches N/A
Completed NCT05153876 - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting NCT06041997 - Smartphone Use Restriction as Treatment of Primary Headache N/A
Active, not recruiting NCT04936321 - Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial N/A
Completed NCT04220580 - Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache N/A
Completed NCT03385174 - Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow N/A
Completed NCT03137147 - Intervention for Sleep and Pain in Youth N/A
Completed NCT02910921 - Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit
Recruiting NCT05619354 - Validity and Reliability of the Dutch HDI
Recruiting NCT06206772 - Resting State Functional Connectivity in Cluster Headache
Terminated NCT02624661 - Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique Phase 1/Phase 2
Completed NCT02662972 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. Phase 1/Phase 2
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT04891848 - Assessment of Inflammation in Primary Headaches
Recruiting NCT04715685 - Mind Body Balance for Pediatric Migraine N/A
Completed NCT00457496 - Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities Phase 3